Document is current
Any future updates will be listed below
-
Authors
Kuklinski, Margaret R. https://orcid.org/0000-0002-3475-4471
Gibbons, Brent J.
Bowser, Diana M.
McCollister, Kathryn E.
Smart, Rosanna
Dunlap, Laura J.
Shenkar, Ella
Bonar, Erin E.
Boomer, Tyra
Campbell, Mark
Fiellin, Lynn E.
Hutton, David W.
Rao, Vinod
Saldana, Lisa
Su, Katherine
Walton, Maureen A.
Yilmazer, Tansel
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (UH3DA050252)
National Institute on Drug Abuse (UH3DA050174)
National Institute on Drug Abuse (UH3DA050193)
National Institute on Drug Abuse (UH3DA050235)
National Institute on Drug Abuse (U24DA050182)
National Institute on Drug Abuse (UH3DA050189)
National Institute on Drug Abuse (UH3DA050250)
National Institute on Drug Abuse (UH3DA050173)
National Institute on Drug Abuse (UH3DA050251)
National Institute on Drug Abuse (P30DA04500)
- License Information
-
More Information
Article History
Received: 9 January 2025
Accepted: 9 August 2025
First Online: 14 October 2025
Declarations
:
: The Institutional Review Boards of Massachusetts General Brigham (MPIs Timothy Wilens, Amy Yule); The Ohio State University (MPIs Natasha Slesnick, Kelly Kelleher); Oregon Social Learning Center and Lighthouse Institute (PI Lisa Saldana); RTI International (MPIs Phillip Graham, Ty Ridenour); Washington State (MPIs Kym Ahrens, Kevin Haggerty); Texas Christian University (PI Danica Knight); University of Michigan Medical School (IRMBED; MPIs Maureen Walton, Erin Bonar); and Yale (PI Lynn Fiellin); and the RAND Human Subjects Protection Committee (MPIs Elizabeth D’Amico, Daniel Dickerson) approved the projects that participated in this study. All procedures with human subjects were performed in accordance with the ethical standards of the institute and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: N/A. This study did not include participant data.
: The authors declare that they have no conflict of interest.
